Contemporary Clinical Trials Communications

SCIE

国际简称：Cont Clin Trial Comm 参考译名：当代临床试验通讯

主要研究方向：Pharmacology, Toxicology and Pharmaceutics-Pharmacology 非预警期刊审稿周期：20 Weeks

《当代临床试验通讯》(Contemporary Clinical Trials Communications)是一本由Elsevier出版的以Pharmacology, Toxicology and Pharmaceutics-Pharmacology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q4 JCR分区
146 年发文量
1.5 IF影响因子
未开放 是否OA
- 出版周期
English 出版语言

Contemporary Clinical Trials Communications is an international, peer-reviewed open access journal dedicated to the field of clinical trials. This journal aims to provide a high-quality communication platform for the design, implementation, analysis, and reporting of clinical trials, in order to promote the development of the fields of medicine and biological sciences. The main goal of the magazine is to publish original research, review articles, case reports, newsletters, conference reports, and other types of articles, covering various stages of clinical trials, including trial design, data collection, statistical analysis, result interpretation, and policy formulation. In addition, the magazine also focuses on ethical issues, patient safety, data management, and regulatory policies in clinical trials. Through high-quality research articles and providing a professional communication platform, this journal is committed to promoting the development of the fields of medicine and biological sciences, providing support for the design, implementation, analysis, and reporting of clinical trials.

[ 查看全部 ]

投稿咨询加急咨询

Contemporary Clinical Trials Communications期刊信息

ISSN：2451-8654
出版语言：English
是否OA：未开放
出版地区：United States
是否预警：否
出版商：Elsevier
出版周期：-
开源占比：0.9524
Gold OA文章占比：100.00%
OA被引用占比：1
出版国人文章占比：0.01
出版撤稿占比：
研究类文章占比：99.32%

Contemporary Clinical Trials Communications CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.6

0.625

0.683

学科类别	分区	排名	百分位
大类：Medicine 小类：General Medicine	Q2	225 / 669	66%
大类：Medicine 小类：Pharmacology	Q3	228 / 328	30%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Contemporary Clinical Trials Communications中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	4区

Contemporary Clinical Trials Communications JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	ESCI	Q4	146 / 191	23.8
学科：MEDICINE, RESEARCH & EXPERIMENTAL	ESCI	Q3	139 / 191	27.49

Contemporary Clinical Trials Communications历年数据统计

影响因子

中科院分区

Contemporary Clinical Trials Communications中国学者发文选摘

1、Activating the vagus nerve-adrenal anti-inflammatory axis to delay aging: A randomized controlled trial protoco
Author: Sun, Chong; Fu, Meihong; Liu, Jiao; Zheng, Kebing; Chen, Shaoping; Deng, Lunsha; Zhuang, Yanping; Wang, Kai; Ren, Ruibao; Liang, Chao

Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2026; Vol. 51, Issue , pp. -. DOI: 10.1016/j.conctc.2026.101632
2、Effects of intermittent theta-burst stimulation (iTBS) on post-stroke depression (PSD): A study protocol for a single-center randomized controlled tria
Author: Zhong, Yanbiao; Ren, Meng; Wang, Wenjing; He, Juanlian; Zhong, Yonghui; Xu, Jingjing; Li, YuanLi; Zhang, Sicong; Shan, Chunlei

Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2026; Vol. 49, Issue , pp. -. DOI: 10.1016/j.conctc.2026.101599
3、Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical tria
Author: Diaz, Jorge; Fonseca, Allex; Yan, Lixin; Liu, Dongfang; Xie, Liangzhi

Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101496
4、SHengXIaN-QuYu DEcoction in the Treatment of Heart Failure with Reduced and Mildly-Reduced Ejection Fraction (SHINE-HF): rationale and design for a multicenter randomized controlled tria
Author: Feng, Lina; Chen, Sizhen; Liu, Jiang; Li, Chunyan; Cao, Hongshuai; Tao, Liyuan; Fang, Fang; Huo, Feijiao; Liu, Lingling; Wubu'er, Palidan; Wang, Ming; Zhao, Xiaohua; Liu, Xiaojian; Xin, Hui; Li, Ding; Mao, Weisheng; Gui, Liang; Guan, Jianfei; Zhu, Zhiyang; Song, Haijun; Li, Shi; Song, Yingjing; Shi, Meiling; Zhang, Chao; Zhang, Zhiying; Li, Huiyun; Wang, Xiaobin; Yang, Baolong; Jin, Zhao; Du, Yifei; Gao, Yonghui; Cao, Lulei; Yang, Jiamei; Wang, Qiao; Kang, Naidan; Su, Lina; Zheng, Zhaoqi; Fan, Jiasai; Xu, Jiaying; Shi, Zaixiang; Ren, Jingyi; SHINE HF Investigator

Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101497
5、A three-arm randomized controlled trial protocol: Effects of telephone-based, layperson-delivered wisdom-enhancement narrative therapy and empathy-focused interventions on loneliness, social, and mental health in older adult
Author: Tang, Vivien Foong Yee; Jiang, Da; Kahlon, Maninder; Chow, Esther Oi-wah; Yeung, Dannii Yuen-lan; Aubrey, Rhonda; Chou, Kee-Lee

Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101479